The evaluation of biomaterials is a critical process that demands meticulous attention to safety and regulatory compliance. Endotoxins and pyrogens pose inherent risks in drugs, medical devices, and biomaterials. As such, utilizing pyrogen and endotoxin testing for the identification and quantification of endotoxins and pyrogens are imperative steps in the assessment of the safety and efficacy of drugs and medical devices.

In this white paper, iFyber experts Fahimeh Tabatabaei, Ph.D., Tricia Conti, MS, and Nicole Byrnes-Shaver, BA share insights on the pivotal role pyrogen and endotoxin testing plays in safeguarding patient well-being and upholding the integrity of drugs and medical devices.

Enter your information below to get your download.